39431014|t|Targeted sonogenetic modulation of GABAergic interneurons in the hippocampal CA1 region in status epilepticus.
39431014|a|Rationale: Sonogenetics is an advanced ultrasound-based neurostimulation approach for targeting neurons in specific brain regions. However, the role of sonogenetics in treating status epilepticus (SE) remains unclear. Here, we aimed to investigate the effects of ultrasound neurostimulation and MscL-G22S (a mechanosensitive ion channel that mediates Ca2+ influx)-mediated sonogenetics (MG-SOG) in a mouse model of kainic acid (KA)-induced SE. Methods: For MG-SOG, a Cre-dependent AAV expressing MscL-G22S was injected into parvalbumin (PV)-cre and somatostatin (SST)-cre mice to induce the expression of MscL-G22S-EGFP in PV interneurons (PV-INs) and SST interneurons (SST-INs), respectively; mice were stimulated with continuous pulses of ultrasound stimulation during the latency of generalized seizures (GSs), the latency to SE, in SE model mice. We performed calcium fiber photometry, patch-clamp recording, local field potential recording, and SE monitoring to investigate the role of MG-SOG in treating SE. Results: First, we observed obvious neuronal activation in the hippocampal CA1 region in SE model mice. Both excitatory neurons (ENs) and GABAergic interneurons (GABA-INs) in the CA1 region were activated in SE model mice; however, the inhibitory effect of GABA-INs on ENs seemed to be insufficient to reduce EN excitability despite the increased activation of GABA-INs in SE model mice. Thus, we speculated that MG-SOG-induced activation of GABA-INs, mainly SST-INs and PV-INs, in the CA1 region may protect against SE. We found that MG-SOG-mediated PV-IN activation in the CA1 region ameliorated SE and changed SE-related electrophysiological abnormalities in the CA1 region; however, MG-SOG-induced SST-IN activation in the CA1 region did not ameliorate SE. Conclusions: MG-SOG-mediated activation of PV-INs had a positive effect on relieving SE. Our work may promote the development of sonogenetic neurostimulation techniques for treating SE.
39431014	91	109	status epilepticus	Disease	MESH:D013226
39431014	288	306	status epilepticus	Disease	MESH:D013226
39431014	308	310	SE	Disease	MESH:D013226
39431014	411	415	G22S	ProteinMutation	tmVar:p|SUB|G|22|S;HGVS:p.G22S;VariantGroup:0;OriginalGene:19293;CorrespondingGene:5816;CorrespondingSpecies:10090
39431014	462	466	Ca2+	Chemical	-
39431014	498	500	MG	Chemical	MESH:D008274
39431014	501	504	SOG	Chemical	-
39431014	511	516	mouse	Species	10090
39431014	526	537	kainic acid	Chemical	MESH:D007608
39431014	539	541	KA	Chemical	MESH:D007608
39431014	551	553	SE	Disease	MESH:D013226
39431014	568	570	MG	CellLine	CVCL:Z093
39431014	571	574	SOG	Chemical	-
39431014	612	616	G22S	ProteinMutation	tmVar:p|SUB|G|22|S;HGVS:p.G22S;VariantGroup:0;OriginalGene:19293;CorrespondingGene:5816;CorrespondingSpecies:10090
39431014	635	646	parvalbumin	Gene	19293
39431014	648	650	PV	Gene	19293
39431014	660	672	somatostatin	Gene	20604
39431014	674	677	SST	Gene	20604
39431014	683	687	mice	Species	10090
39431014	721	725	G22S	ProteinMutation	tmVar:p|SUB|G|22|S;HGVS:p.G22S;VariantGroup:0;OriginalGene:19293;CorrespondingGene:5816;CorrespondingSpecies:10090
39431014	734	736	PV	Gene	19293
39431014	751	753	PV	Gene	19293
39431014	763	766	SST	Gene	20604
39431014	781	784	SST	Gene	20604
39431014	805	809	mice	Species	10090
39431014	897	917	generalized seizures	Disease	MESH:D012640
39431014	919	922	GSs	Disease	MESH:D012640
39431014	940	942	SE	Disease	MESH:D013226
39431014	947	949	SE	Disease	MESH:D013226
39431014	956	960	mice	Species	10090
39431014	975	982	calcium	Chemical	MESH:D002118
39431014	1061	1063	SE	Disease	MESH:D013226
39431014	1102	1104	MG	Chemical	MESH:D008274
39431014	1105	1108	SOG	Chemical	-
39431014	1121	1123	SE	Disease	MESH:D013226
39431014	1214	1216	SE	Disease	MESH:D013226
39431014	1223	1227	mice	Species	10090
39431014	1287	1291	GABA	Chemical	MESH:D005680
39431014	1333	1335	SE	Disease	MESH:D013226
39431014	1342	1346	mice	Species	10090
39431014	1382	1386	GABA	Chemical	MESH:D005680
39431014	1486	1490	GABA	Chemical	MESH:D005680
39431014	1498	1500	SE	Disease	MESH:D013226
39431014	1507	1511	mice	Species	10090
39431014	1538	1540	MG	Chemical	MESH:D008274
39431014	1541	1544	SOG	Chemical	-
39431014	1567	1571	GABA	Chemical	MESH:D005680
39431014	1584	1587	SST	Gene	20604
39431014	1596	1598	PV	Gene	19293
39431014	1642	1644	SE	Disease	MESH:D013226
39431014	1660	1662	MG	Chemical	MESH:D008274
39431014	1663	1666	SOG	Chemical	-
39431014	1676	1678	PV	Gene	19293
39431014	1723	1725	SE	Disease	MESH:D013226
39431014	1738	1740	SE	Disease	MESH:D013226
39431014	1812	1814	MG	Chemical	MESH:D008274
39431014	1815	1818	SOG	Chemical	-
39431014	1827	1830	SST	Gene	20604
39431014	1882	1884	SE	Disease	MESH:D013226
39431014	1899	1901	MG	Chemical	MESH:D008274
39431014	1902	1905	SOG	Chemical	-
39431014	1929	1931	PV	Gene	19293
39431014	1971	1973	SE	Disease	MESH:D013226
39431014	2068	2070	SE	Disease	MESH:D013226
39431014	Association	MESH:D008274	HGVS:p.G22S;CorrespondingGene:5816
39431014	Association	20604	HGVS:p.G22S;CorrespondingGene:5816
39431014	Association	MESH:D013226	HGVS:p.G22S;CorrespondingGene:5816
39431014	Association	19293	HGVS:p.G22S;CorrespondingGene:5816
39431014	Positive_Correlation	MESH:D008274	19293
39431014	Positive_Correlation	MESH:D005680	MESH:D008274
39431014	Positive_Correlation	MESH:D007608	MESH:D013226
39431014	Association	MESH:D005680	MESH:D013226
39431014	Negative_Correlation	MESH:D008274	MESH:D013226
39431014	Positive_Correlation	MESH:D008274	20604
39431014	Association	MESH:D013226	5816

